Evofem Biosciences, Inc. (EVFM)
OTCMKTS · Delayed Price · Currency is USD
0.0076
-0.0004 (-5.00%)
At close: Aug 19, 2026
Evofem Biosciences Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | -15.28 | 0.39 | -8.86 | 52.98 | -76.7 | -205.19 |
Depreciation & Amortization | 0.39 | 0.63 | 0.76 | 1.78 | 1.02 | 1.02 |
Loss (Gain) From Sale of Assets | - | 0.02 | 0.73 | 2.51 | 0.93 | - |
Stock-Based Compensation | 0.08 | 0.17 | 0.85 | 1.19 | 3.31 | 8.9 |
Other Operating Activities | 11.58 | -3.78 | 1.77 | -72.16 | -4.98 | 38.03 |
Change in Accounts Receivable | 2.44 | -2.65 | -4.09 | -4.61 | 5.32 | -5.38 |
Change in Inventory | -0.78 | -0.26 | 0.06 | 2.11 | 1.57 | -0.02 |
Change in Accounts Payable | -0.69 | 0.18 | -0.91 | 4.09 | 4.47 | -0 |
Change in Other Net Operating Assets | 1.79 | 3.31 | 5.81 | 3.14 | -5.35 | 15.99 |
Operating Cash Flow | -0.47 | -1.99 | -3.89 | -8.97 | -70.41 | -146.67 |
Operating Cash Flow Growth | - | - | - | - | - | - |
Capital Expenditures | -0.01 | -0.01 | -0.01 | -0 | -0.34 | -2.94 |
Divestitures | - | - | - | - | - | 0.25 |
Sale (Purchase) of Intangibles | - | -0.06 | -0.56 | - | - | - |
Investing Cash Flow | -0.01 | -0.06 | -0.57 | -0 | -0.34 | -2.69 |
Short-Term Debt Issued | - | 0.38 | 0.4 | 5.64 | - | - |
Long-Term Debt Issued | - | 2.43 | - | - | 11.5 | - |
Total Debt Issued | 1.07 | 2.81 | 0.4 | 5.64 | 11.5 | - |
Short-Term Debt Repaid | - | -0.91 | -0.78 | - | - | - |
Long-Term Debt Repaid | - | - | - | -1.15 | -5.89 | - |
Total Debt Repaid | -1.04 | -0.91 | -0.78 | -1.15 | -5.89 | - |
Net Debt Issued (Repaid) | 0.03 | 1.9 | -0.39 | 4.49 | 5.61 | - |
Issuance of Common Stock | - | - | 5 | 0.29 | 57.55 | 81.99 |
Repurchase of Common Stock | - | - | - | - | -0.02 | -0.33 |
Other Financing Activities | -0.01 | -0.01 | - | - | -1.2 | -0.97 |
Financing Cash Flow | 0.01 | 1.89 | 4.62 | 4.78 | 61.94 | 90.69 |
Net Cash Flow | -0.46 | -0.16 | 0.16 | -4.2 | -8.81 | -58.66 |
Free Cash Flow | -0.48 | -2 | -3.9 | -8.97 | -70.75 | -149.61 |
Free Cash Flow Growth | - | - | - | - | - | - |
Free Cash Flow Margin | -2.64% | -9.89% | -20.14% | -49.25% | -420.21% | -1814.73% |
Free Cash Flow Per Share | -0.00 | - | -0.05 | -0.01 | -151.84 | -2142.80 |
Levered Free Cash Flow | 6.35 | -5.85 | -4.33 | -5.77 | -37.99 | -69.98 |
Unlevered Free Cash Flow | 8 | -4.2 | -2.72 | -4.13 | -36.68 | -67.02 |
Cash Interest Paid | 0.02 | 0.02 | 0.16 | 0.34 | 0.7 | 1.39 |
Cash Income Tax Paid | 0 | 0 | 0.01 | 0 | 0.03 | 0.01 |
Change in Working Capital | 2.76 | 0.58 | 0.87 | 4.73 | 6.02 | 10.58 |